Lowell Farms Inc. (OTCPK: LOWL.F)
Health Care · Pharmaceuticals · US
$0.00
— today · -100.0% 1Y
Lowell Farms Inc. (OTCPK: LOWL.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $18.00 and employs 96 people.
Over the last twelve months the share price has lost 100.0%, trading between 0.00 and 0.02.
Tweenvest scores Lowell Farms Inc. across four factors: quality 31/100, value 51/100, growth 63/100. Its strongest factor is growth.
LOWL.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.00
- Revenue (TTM)
- $19.15M
- P/E
- —
- EPS
- -1.08
- Dividend yield
- —
- Beta (5Y)
- 3.44
- 52-week high
- $0.02
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.15M
- Employees
- 96
- Next earnings
- —
About Lowell Farms Inc.
Lowell Farms Inc. engages in the cultivation, extraction, manufacturing, sale, marketing, and distribution of cannabis products to retail dispensaries in California. The company provides flowers, vape pens, oils, extracts, chocolate edibles, mints, gummies, topicals, tinctures, and pre-rolls under the Lowell Herb Co., Lowell Smokes, Cypress Reserve, Flavor Extracts, Kaizen, House Weed, Moon, Altai, Humble Flower, Original Pot Company, and CannaStripe brands. It also offers manufacturing, extraction, and distribution services to third-party cannabis and cannabis branding companies. The company was formerly known as Indus Holdings, Inc. and changed its name to Lowell Farms Inc. in March 2021. Lowell Farms Inc. was founded in 2014 and is based in Salinas, California.
- ISIN
- CA5475722065
- Founded
- 2014
- Listed since
- Mar 29, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.